3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Colorectal Neoplasms
58
Carcinoma, Non-Small-Cell Lung
29
Breast Neoplasms
18
Rectal Neoplasms
14
Ovarian Neoplasms
14
Neoplasm Metastasis
10
Carcinoma, Hepatocellular
10
Glioblastoma
9
Colonic Neoplasms
9
Carcinoma, Renal Cell
8
Uterine Cervical Neoplasms
7
Fallopian Tube Neoplasms
7
Brain Neoplasms
6
Neoplasms
5
Nasopharyngeal Carcinoma
5
Lung Neoplasms
5
Triple Negative Breast Neoplasms
4
Recurrence
4
Liver Neoplasms
4
Inflammatory Breast Neoplasms
4
Colorectal Cancer Metastatic
4
Carcinoma, Ovarian Epithelial
4
Stomach Neoplasms
3
Pleural Effusion, Malignant
3
Meningeal Carcinomatosis
3
Melanoma
3
Kidney Neoplasms
3
Glioma
3
Non-squamous Non-small Cell Lung Cancer
2
Liver Metastasis Colon Cancer
2
Interventions
Cisplatin
4
tremelimumab
3
Pemetrexed
3
durvalumab
2
atezolizumab
2
Radiotherapy
2
Nivolumab
2
Mitomycin
2
Doxorubicin
2
toripalimab
1
talazoparib
1
rucaparib
1
regorafenib
1
ranpirnase
1
pembrolizumab
1
niraparib
1
liposomal doxorubicin
1
dostarlimab
1
cemiplimab
1
bemcentinib
1
avelumab
1
abemaciclib
1
Vinorelbine
1
Vinblastine
1
Thiostrepton
1
Surgical Procedures, Operative
1
Oxaliplatin
1
One-Lung Ventilation
1
Neoadjuvant Therapy
1
Megestrol Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Mesothelioma, Malignant
×
Bevacizumab
×
Clear all
NCT03654833
2023-03-14
MiST
University of Leicester
Phase 2
Unknown
186 enrolled